Show simple item record

 
dc.contributorConsorci Sanitari de Terrassa
dc.contributor.authorPlaza Diaz, Adrian
dc.contributor.authorJuanes Borrego, Ana
dc.contributor.authorSanz-Lopez, Natalia
dc.contributor.authorGonzález Bueno, Javier
dc.contributor.authorFernández-Morató, Jordi
dc.contributor.authorGarcia-Pelaez, Milagros
dc.date.accessioned2025-10-27T13:44:32Z
dc.date.available2025-10-27T13:44:32Z
dc.date.issued2025-09-29
dc.identifier.citationPlaza-Díaz A, Juanes-Borrego A, Sanz-Lopez N, González-Bueno J, Fernández-Morató J, García-Peláez M, et al. Emergency Department Reconsultations After a Secondary Prevention Bundle for Medication-Related Problems: A Retrospective Cohort Study. J Clin Med. 2025 Sep 29;14(19):6907.
dc.identifier.issn2077-0383
dc.identifier.urihttp://hdl.handle.net/11351/13942
dc.descriptionDrug-related problems; Emergency department; Older adults; Readmission; Secondary prevention
dc.description.abstractBackground/Objective: Drug-related problems (DRPs) are a common, potentially avoidable cause of emergency department (ED) use. In December 2022, our hospital integrated a pharmacist-led intervention into routine ED practice. This intervention comprised medication optimization, adherence counseling, and coordinated hand-off to primary care. We quantified 30- and 90-day reconsultations after discharge and explored factors associated with DRP-related revisits. Methods: A retrospective cohort of adults (≥18 years) who attended a tertiary ED (Barcelona, Spain). We included index DRP visits from 1 December 2022 to 30 June 2024. All received the bundle. Demographic, clinical, and pharmacotherapeutic data were extracted from the Catalan Shared Health Record; an independent committee classified revisits as a DRP or non-DRP. Predictors of 30-day DRP revisits were assessed with multivariable logistic regression. Results: Among 1247 patients (mean age 78.6 ± 16.2 years; 59.2% women; and median nine drugs), 120 (9.6%) reconsulted the ED within 30 days, and 194 (15.5%) within 90 days for any cause. DRP-specific rates were 30.8% (37/120) at 30 days and 26.3% (51/194) at 90 days; 81% and 80% of these revisits, respectively, involved a recurrence of the same DRP. The most frequent index DRPs were constipation (14.2%), gastrointestinal bleeding (9.2%), hypertension (8.3%), seizures (8.3%) and hyponatraemia (6.7%). An age ≥ 80 years independently predicted fewer 30-day DRP revisits (OR 0.32; 95% CI 0.13-0.79); hypertension and cognitive impairment were not significant after adjustment. Conclusions: In this single-arm implementation cohort, overall, 30-day ED reconsultations were 9.6% and about one-third were DRP-related, predominantly recurrences, and chiefly gastrointestinal bleeding and seizures. These descriptive findings should be interpreted cautiously given potential survivorship bias and residual confounding; the apparently lower risk among patients aged ≥ 80 years is hypothesis-generating and may reflect geriatric care pathways and caregiver engagement. Targeted post-discharge monitoring for high-recurrence DRPs may help reduce avoidable ED use, and future evaluations should test this in quasi-experimental or randomized designs.
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesJournal of clinical medicine;14(19)
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectHospitals - Serveis d'urgències
dc.subjectMedicaments - Efectes secundaris
dc.subjectRaonament basat en casos
dc.subject.meshEmergency Medical Services
dc.subject.meshDrug-Related Side Effects and Adverse Reactions
dc.subject.meshCohort Studies
dc.titleEmergency Department Reconsultations After a Secondary Prevention Bundle for Medication-Related Problems: A Retrospective Cohort Study
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/jcm14196907
dc.subject.decsservicios médicos de urgencia
dc.subject.decsefectos colaterales y reacciones adversas relacionados con medicamentos
dc.subject.decsestudios de cohortes
dc.relation.publishversionhttps://www.doi.org/10.3390/jcm14196907
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.authoraffiliation[Plaza-Díaz A] Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain. Department of Medicine, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Juanes-Borrego A] Pharmacy Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Institut de Recerca Sant Pau (IR SANT PAU), Barcelona, Spain. [Sanz-Lopez N] Emergency Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [González-Bueno J] Pharmacy Department, Hospital Dos de Maig Consorci Sanitari Integral, Barcelona, Spain. Central Catalonia Chronicity Research Group (C3RG), University of Vic-Central University of Catalonia (UVIC-UCC), Vic, Spain. [Fernández-Morató J] Pharmacy Department, Consorci Sanitari de Terrassa, Terrassa, Spain. [García-Peláez M] Pharmacy Department, Hospital General de Granollers, Granollers, Spain
dc.identifier.pmid41095987
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record